chartexchange

CDNA
CareDx, Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
74.43USD-0.174%(-0.13)537,509
After-hoursNov 18, 2026 4:33:30 PM EST
75.92USD+2.002%(+1.49)
Loading…
Loading…
Healthcare
Diagnostics & Research
CEO
Peter Maag
HQ
South San Francisco, CA, USA
Previous Close
$74.56
Beta
1.25
52-Week High
$90.87 2026-10-30
52-Week Low
$15.56 2026-04-10
SMA 50
$67.77
SMA 200
$37.51
Avg. Vol 10D
987,907
Avg. Vol 30D
1.26M
Avg. Vol 90D
1.30M
Relative Vol
0.43
50.80M
0.2800%
137
CDNA Profile

caredx: transforming transplant patient care through novel surveillance management solutions caredx, inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. by combining the latest advances in genomics and bioinformatics technology, with a commitment to generating high quality clinical evidence through trials and registries, caredx is at the forefront of organ transplant surveillance and pre-transplant hla typing solutions. nasdaq:cdna about allosure® allosure is the first and only non-invasive blood test that directly measures allograft injury and identifies the probability of active rejection to better manage kidney transplant patients. allosure is a clinical-grade, proprietary next-generation sequencing (ngs) based test to detect donor-derived cell-free dna (dd-cfdna) in order to identify organ injury in kidney transplant recipients. allosure is analytically validated as a sensitive, specific, and precise measurement of dd-cfdna. allos

CDNA Performance
PeriodPriceDateChangeBeta
1W79.812026-11-12-6.85%2.316
1M67.082026-10-19+10.82%1.182
3M46.512026-08-19+59.84%1.257
6M20.532026-05-19+262.10%1.171
1Y15.982025-11-19+365.21%1.254
2Y22.062024-11-19+236.99%—
5Y43.012021-11-19+72.84%1.539
CDNA Stock Summary

CareDx, Inc. (NASDAQ:CDNA) stock price today is $74.34, and today's volume is 537,509. CDNA is down 0.295% today. The 30 day average volume is 1.26M. CDNA market cap is $3.91B with 52.54M shares outstanding.